Like Artemis Health

closed 1/7/2022 via BusinessWire

Nomi Health, Inc., acquired Artemis Health

synopsis: Nomi Health, the leading direct healthcare provider in America, has acquired Artemis Health, a healthcare analytics provider. The acquisition gives Nomi Health customers actionable, data-driven insights to materially lower costs and improve the quality of care they deliver to their communities.
buyer: Nomi Health, Inc.
Nomi Health is a direct healthcare company successfully re-wiring how healthcare is bought, paid for and delivered in America, to the benefit of patients, providers and the buyers of healthcare in both the public and private sectors. "
target: Artemis Health
Artemis Health helps self-insured employers, employee benefits consultants, and benefits brokers with benefits data analytics and healthcare analytics software. The company's data optimization platform enables benefits teams to quantify the impact of their programs and justify new programs.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via BusinessWire

Ceridian Corporation, acquired Clearview Logix, LLC

synopsis: Ceridian, a global human capital management (HCM) cloud-based technology company, announced its acquisition of substantially all of the assets of Clearview Logix, a Richmond, Virginia-based leading decision-support analytics company, Clearview Logix builds analytics models to simplify health insurance choices for employees, employers, and their ad
buyer parent: Thomas H. Lee Partners, L.P.
buyer: Ceridian Corporation (:$964.90)
Ceridian is a global human capital management software company. Dayforce, their flagship cloud HCM platform, provides human resources, payroll, benefits, workforce management, and talent management functionality. "
target: Clearview Logix, LLC
Clearview Logix builds analytics models to simplify health insurance choices for employees, employers, and their administrative partners.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/12/2017 via PR Newswire

UPMC WorkPartners, acquired HCMS Group LLC

synopsis: UPMC WorkPartners, a leading provider of integrated health and productivity solutions, has acquired HCMS Group, a privately-held health information service company. HCMS Group offers cloud-based solutions that provide essential health information for better decision-making.
buyer parent: UPMC
buyer: UPMC WorkPartners
UPMC WorkPartners provides health and productivity solutions to high-performing companies throughout the US. Their product portfolio includes tailored health management and wellness offerings, employee assistance programs, workers' compensation coverage, employee health services, and more. "
target: HCMS Group LLC
HCMS Group is an independent health information service company providing cloud-based solutions to self-insured employers, health & disability insurance plans, health service providers, and health benefits consultants. They provide the health information essential for better decision-making.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/16/2011 via BusinessWire

Dohmen Company, acquired PlanIT, Incorporated

synopsis: Dohmen Company, a family-owned health care services business, has announced that the Dohmen Investment Group acquired PlanIT, Incorporated, a health care analytics company based in Germantown, Wis.
buyer: Dohmen Company
Dohmen is a fifth-generation, family-owned health care services business. Dohmen’s portfolio of service offerings includes outsourced business services to life science manufacturers through DDN and DDN Medical Affairs, and benefit management services to life science payers through Restat and Align. "
target: PlanIT, Incorporated
PlanIT, Incorporated is a leading provider of group health analytic services. Its signature product – Health Plan Intelligence (HPI) – is an integrated service package which includes: HPI-Portal, HPI-Dashboard, HPI-Analytics, and HPI-BeneCal.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/17/2021 via GlobeNewswire

Benefitfocus, Inc., acquired Tango Health

synopsis: Benefitfocus, Inc., an industry-leading benefits technology platform that simplifies benefits administration for employers, health plans and brokers, announced it has acquired Tango Health, an innovative software and services company offering Affordable Care Act (ACA) compliance and benefit decision support solutions.
buyer: Benefitfocus, Inc. (BNFT:$264.22)
Benefitfocus unifies the entire benefits industry through innovative technology solutions that bring efficiency, cost savings and simplicity to employee benefits administration. "
target: Tango Health
Tango Health is a leading software and services company focused on supporting organizations to deliver a better benefits experience. Tango Health’s flexible solutions include decision support, benefits engagement, virtual open enrollment, and full-service ACA compliance and reporting.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/11/2021 via PR Newswire

Equifax, Inc., will acquire Health E(fx)

synopsis: Equifax has signed a definitive agreement to acquire Health e(fx). The first company to truly solve the ACA (Affordable Care Act) compliance challenge, Health e(fx) brings the leading end-to-end workforce management, compliance, reporting, and analytics solution on the market today.
buyer: Equifax, Inc. (NYSE:EFX:$4,634.50)
Equifax is a global data, analytics, and technology company, they play an essential role in the global economy by helping financial institutions, companies, employees, and government agencies make critical decisions with greater confidence. "
target: Health E(fx)
The first company to truly solve the ACA (Affordable Care Act) compliance challenge, Health e(fx) brings the leading end-to-end workforce management, compliance, reporting, and analytics solution on the market today.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/11/2015 via BusinessWire

Towers Watson, acquired Acclaris, Inc

synopsis: Towers Watson, a global professional services company, announced that it has acquired Acclaris, a provider of software-as-a-service (SaaS)-based technology and services for consumer-driven health care and reimbursement accounts, including health savings accounts (HSAs), health reimbursement arrangements (HRAs) and other consumer directed accounts.
buyer: Towers Watson (TW:$3,644.95)
Towers Watson is a leading global professional services company that helps organizations improve performance through effective people, risk and financial management. Towers Watson offers solutions in the areas of employee benefits, talent management, rewards, and risk and capital management. "
target parent: Staley Capital
target: Acclaris, Inc
Acclaris provides the services and technology that health plans, benefit consultants and financial institutions rely on to deliver health care and reimbursement accounts to a growing market.
price ($mm)
$140
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2011 via Company Description

Aetna Inc., acquired PayFlex Systems USA, Inc.

synopsis: As of October 3, 2011, PayFlex was acquired by Aetna. PayFlex Systems USA provides proprietary web-based benefit administration services and solutions for plan sponsors who offer consumer-based products such as Health Savings Accounts, Health Reimbursement Accounts and Flexible Spending Accounts.
buyer: Aetna Inc. (AET:$60,705.00)
Aetna is one of the nation’s leading diversified health care benefits companies, serving approximately 33.8 million people with information and resources to help them make better informed decisions about their health care. "
target parent: Oak Investment Partners
target: PayFlex Systems USA, Inc.
PayFlex Systems USA provides proprietary web-based benefit administration services and solutions for plan sponsors who offer consumer-based products such as Health Savings Accounts (HSAs), Health Reimbursement Accounts (HRAs) and Flexible Spending Accounts (FSAs).
price ($mm)
$202
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/16/2008 via

Metavante Corporation, acquired BenSoft Incorporated

synopsis: Metavante, a leading provider of banking and payments technology, today announced its plans to acquire BenSoft Incorporated, of San Diego, Calif., and its product, RepayMe. Metavante will integrate RepayMe into its existing Healthcare Payment Solutions suite of products.
buyer: Metavante Corporation (MV:$0.00)
Metavante Corporation provides banking and payment technologies to financial services firms and businesses. Its products and services include account processing for deposit, loan, and trust systems, image based and conventional check processing, and electronic funds transfer. "
target: BenSoft Incorporated
RepayMe is an offering of BenSoft Incorporated and one of the pioneers of Web-based benefits administration technology for the management of consumer-driven healthcare plans.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/18/2019 via BNC Analysis

ELMC Risk Solutions, acquired Tesser Health

synopsis: Tesser Health has been acquired by ELMC Risk Solutions. ELMC announced that the Miami-based digital health company will become the Tesser Health division of ELMCRx Solutions. Tesser Health helps employers and their employees save money on prescription drugs through an evidence-based platform that is designed to help members make better choices.
buyer: ELMC Risk Solutions
ELMC Risk Solutions, LLC is a premier organization comprised of the country’s finest MGUs (Managing General Underwriters). Their companies specialize in medical and Rx stop loss and reinsurance coverage and PBM (pharmacy benefit manager) consulting. "
target: Tesser Health
Since 2014, Tesser Health has helped employers and their employees save money on prescription drugs. Their evidence-based platform is designed to help members make better choices about their medications through personal outreach.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/25/2021 via PR Web

Simplify Compliance, acquired BasicSafe

synopsis: Simplify Compliance, a leading provider of business information and training solutions, announces the acquisition of BasicSafe, a scalable, web-based system that streamlines environmental health and safety (EHS) workflow management. The BasicSafe applications will complement Simplify Compliance’s existing safety platform, EHS Hero.
buyer parent: Leeds Equity Partners
buyer: Simplify Compliance
Simplify Compliance, a Leeds Equity Partners-backed portfolio company, helps its customers learn, comply, and succeed by providing mission-critical regulatory and business information, analysis, and tools. Simplify Compliance helps businesses, and their employees monitor compliance. "
target: BasicSafe
BasicSafe is an internet-based integrated approach to managing safe work cultures and compliance with regulatory requirements. Extensive programming based on proven safety methodologies that target employee training and information access are the backbone of the BasicSafe suite.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/31/2021 via BusinessWire

IBH Population Health Solutions, acquired Uprise Employee Assitance

synopsis: IBH, a leader in population and digital health services, is proud to announce the acquisition of Uprise, a digital health platform delivering highly-personalized care through self-guided modules, live coaching, and in-person therapy.
buyer parent: Periscope Equity
buyer: IBH Population Health Solutions
IBH Population Health Solutions is a pioneer in managed behavioral health, integrated employee assistance programs, and services. They deliver world class Employee Assistance Programs, Managed Behavioral Health, Wellness, Data Analytics, and Opioid Assessment and Treatment Solutions. "
target: Uprise Employee Assitance
Uprise, based in Australia, is a mental health and performance improvement solution for businesses. This award-winning solution helps HR improve employee engagement, retention and performance by proactively engaging staff, using clinically proven psychological techniques delivered via mobile app.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2022 via BusinessWire

Nomi Health, Inc., acquired Artemis Health

synopsis: Nomi Health, the leading direct healthcare provider in America, has acquired Artemis Health, a healthcare analytics provider. The acquisition gives Nomi Health customers actionable, data-driven insights to materially lower costs and improve the quality of care they deliver to their communities.
buyer: Nomi Health, Inc.
Nomi Health is a direct healthcare company successfully re-wiring how healthcare is bought, paid for and delivered in America, to the benefit of patients, providers and the buyers of healthcare in both the public and private sectors. "
target: Artemis Health
Artemis Health helps self-insured employers, employee benefits consultants, and benefits brokers with benefits data analytics and healthcare analytics software. The company's data optimization platform enables benefits teams to quantify the impact of their programs and justify new programs.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2022 via BusinessWire

Nomi Health, Inc., acquired Artemis Health

synopsis: Nomi Health, the leading direct healthcare provider in America, has acquired Artemis Health, a healthcare analytics provider. The acquisition gives Nomi Health customers actionable, data-driven insights to materially lower costs and improve the quality of care they deliver to their communities.
buyer: Nomi Health, Inc.
Nomi Health is a direct healthcare company successfully re-wiring how healthcare is bought, paid for and delivered in America, to the benefit of patients, providers and the buyers of healthcare in both the public and private sectors. "
target: Artemis Health
Artemis Health helps self-insured employers, employee benefits consultants, and benefits brokers with benefits data analytics and healthcare analytics software. The company's data optimization platform enables benefits teams to quantify the impact of their programs and justify new programs.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/18/2009 via BusinessWire

United BioSource Corporation, acquired Healthcare Project Management

synopsis: United BioSource Corporation has announced the acquisition of HPM (Geneva) SA, a Geneva, Switzerland-based provider of drug safety and pharmacovigilance services, further extending UBC’s reach into the European market.
buyer parent: Oak Investment Partners
buyer: United BioSource Corporation
United BioSource Corporation accelerates the generation, analysis and communication of real world evidence by integrating scientific and operational expertise with innovative technology solutions to support global development and commercialization of medical products for life science companies. "
target: Healthcare Project Management
Healthcare Project Management (HPM) is a contract research organization founded in 1997 to provide clinical research services to industry as well as academia. Our core services are drug safety, medical writing and scientific consultancy.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/15/2009 via BusinessWire

Beckman Coulter, Inc., acquired Cogenics

synopsis: Clinical Data, Inc. announced that it has completed the sale of Cogenics, the Company’s genomics services division, to Beckman Coulter, Inc. As previously announced, the sale achieves Clinical Data’s goal to monetize non-core assets and focus resources on advancing its two late-stage targeted therapeutic programs.
buyer: Beckman Coulter, Inc. (BEC:$3,260.60)
Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. "
target parent: Clinical Data, Inc.
target: Cogenics
Cogenics’ genomics solutions span current and next generation sequencing, gene expression, clinical and non-clinical genotyping, biomanufacturing support, nucleic acid extraction and biobanking for both research and regulated environments.
price ($mm)
$14
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/14/2008 via BusinessWire

ICON Plc, acquired Prevalere Life Sciences, Inc.

synopsis: ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced that is has acquired Prevalere Life Sciences Inc., a wholly owned subsidiary of ORS Labs Inc.
buyer: ICON Plc (ICLR:$1,541.91)
ICON Clinical Research is a full service clinical research organization providing a comprehensive range of clinical services in Phase I-IV clinical trials to the pharmaceutical, biotechnology and device industries. "
target parent: Oneida Research Services, Inc.
target: Prevalere Life Sciences, Inc.
Prevalere Life Sciences, Inc. is a contract research organization providing consulting and GLP/cGMP compliant analytical testing services to meet the research and development challenges of the pharmaceutical and biotechnology industries.
price ($mm)
$38
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/25/2017 via BusinessWire

Konica Minolta, Inc., will acquire Invicro, LLC

synopsis: Konica Minolta, Inc. and Boston-based Invicro LLC announced that they have concluded an agreement whereby Konica Minolta will acquire Invicro, a leading provider of imaging services and software for research and drug development.
buyer: Konica Minolta, Inc. (TSE:4902:$8,793.96)
Konica Minolta, Inc. is a Japanese technology company headquartered in Tokyo. The company manufactures business and industrial imaging products, including copiers, laser printers, multi-functional peripherals (MFPs) and digital print systems for the production printing market. "
target: Invicro, LLC
Invicro is a leading provider of imaging services and software for research and drug development. Headquartered in Boston, Massachusetts, Invicro LLC was founded in 2008 with the mission of improving the role and function of imaging in drug discovery and development across all therapeutic areas.
price ($mm)
rev ($mm)
$106
EBITDA ($mm)
$17
EV / rev
0.0x
EV / EBITDA
0.0x
closed 8/16/2017 via BusinessWire

Evotec BioSystems GmbH, acquired Aptuit, Inc.

synopsis: Evotec announced that it has successfully completed the acquisition of Aptuit, a partner research organisation for integrated outsourced drug discovery and development solutions. This acquisition adds considerable business opportunities to further accelerate Evotec's long-term strategy to be the industry partner of choice for external innovation.
buyer: Evotec BioSystems GmbH (XTRA:EVT:$226.46)
Founded in Hamburg Germany, Evotec BioSystems GmbH is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. "
target parent: Welsh, Carson, Anderson & Stowe
target: Aptuit, Inc.
Aptuit, Inc. (formerly Global Pharmaceutical Development, Inc.) is an emerging company focused on streamlining and supporting the drug development process for biotechnology and pharmaceutical innovators.
price ($mm)
$300
rev ($mm)
$93
EBITDA ($mm)
$12
EV / rev
3.2x
EV / EBITDA
25.8x
announced 6/20/2017 via Company Press Release

Pamplona Capital Management LLP, will acquire PAREXEL International Corporation

synopsis: Pamplona Capital Management, LLP has entered into a definitive agreement to acquire all of the outstanding shares of PAREXEL International Corporation, a leading global biopharmaceutical services provider. PAREXEL provides a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services.
buyer: Pamplona Capital Management LLP
Pamplona Capital Management is a London, New York, and Boston-based specialist investment manager established in 2005 that provides an alternative investment platform across private equity, fund of hedge funds, and single-manager hedge fund investments. "
target: PAREXEL International Corporation (PRXL:$1,939.36)
PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries.
price ($mm)[EV]
$4,508 [$4,923]
rev ($mm)
$2,097
EBITDA ($mm)
$343
EV / rev
2.4x
EV / EBITDA
14.6x
closed 5/24/2017 via BNC Analysis

ERT, acquired ImageIQ

synopsis: ERT - a provider of clinical trial services - announced the acquisition of ImageIQ, an imaging software and contract research organization and software developer for customized imaging and analysis.
buyer parent: Nordic Capital
buyer: ERT
ERT is a leading provider of high-quality patient data collection solutions for use in clinical drug development. ERT delivers a combination of technology, services and clinical consulting that increase the accuracy and reliability of patient data and improve the widely deployed solutions. "
target: ImageIQ
ImageIQ is an imaging software and contract research organization and software developer for customized imaging and analysis.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/10/2017 via BNC Analysis

inVentiv Health, Inc. will be merged with INC Research, Inc.,

synopsis: INC Research Holdings, Inc., a leading global Phase I-IV Contract Research Organization ("CRO"), and inVentiv Health, Inc., a leading, global CRO and Contract Commercial Organization will merge. INC Research shareholders will own approximately 53 percent and inVentiv shareholders will own approximately 47 percent of the merged entity.
buyer: INC Research, Inc. (SYNH:$4,730.38)
INC Research is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. "
target parent: Thomas H. Lee Partners, L.P.
target: inVentiv Health, Inc.
inVentiv Health is a global professional services organization designed to help the biopharmaceutical industry accelerate the delivery of much-needed therapies to market. Their Clinical Research Organization (CRO) and Contract Commercial Organization (CCO) offer a differentiated suite of services.
price ($mm)[EV]
$2,453 [$4,552]
rev ($mm)
$2,156
EBITDA ($mm)
$306
EV / rev
2.1x
EV / EBITDA
14.9x
closed 10/3/2016 via BusinessWire

Quintiles Transnational Corp. merged with IMS Health Incorporated,

synopsis: Quintiles IMS Holdings, Inc. announced that it has successfully completed its merger of equals transaction between IMS Health Holdings, Inc. and Quintiles Transnational Holdings Inc. The merger creates a leading information and tech-enabled global healthcare service provider, and a full suite of end-to-end clinical and commercial offerings.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the world’s largest provider of biopharmaceutical development services and commercial outsourcing services. They help customers navigate the increasingly complex healthcare environment to improve efficiency and to deliver better healthcare outcomes.
price ($mm)
$8,750
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/14/2009 via BusinessWire

NexMed, Inc., acquired Bio-Quant, Inc.

synopsis: NexMed, Inc., a developer of products based on the NexACT® technology, announced the closing of its acquisition of Bio-Quant, Inc., a privately-held leading research organization for in vitro and in vivo contract drug discovery and pre-clinical development services, headquartered in San Diego, CA.
buyer: NexMed, Inc. (NEXM:$0.00)
NexMed is an innovative drug developer that is leveraging its proprietary NexACT® drug delivery technology to produce a host of new medical treatments. NexMed’s drugs address a variety of health conditions, such as nail fungus, sexual disorders and more. "
target: Bio-Quant, Inc.
Founded in 1999, Bio-Quant is the largest specialty CRO based in San Diego and is one of the industry's most experienced CROs for in vitro and in vivo pharmacology services and research models specializing in oncology, inflammation, immunology, and metabolic diseases, including diabetes.
price ($mm)[EV]
$13 [$13]
rev ($mm)
$5
EBITDA ($mm)
EV / rev
2.5x
EV / EBITDA
closed 11/30/2009 via BusinessWire

PPD, Inc., acquired BioDuro, LLC

synopsis: PPD, Inc. announced it has completed its acquisition of BioDuro LLC, a drug discovery outsourcing company focused on integrated drug discovery programs and services. With this acquisition, PPD now employs more than 1,400 in Asia Pacific and nearly 1,000 people in China.
buyer: PPD, Inc.
PPD is a leading global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. PPD's clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. "
target: BioDuro, LLC
BioDuro is a US-based, fully-integrated, end-to-end global life science outsourcing services company with a team of over 630 in Beijing, China. Our priority is providing the highest quality, FDA-compliant services at an affordable cost.
price ($mm)
$49
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/6/2009 via BusinessWire

PPD, Inc., acquired Excel PharmaStudies Inc.

synopsis: PPD, Inc. announced it has completed its acquisition of Excel PharmaStudies, Inc., one of the largest contract research organizations in China. The acquisition strengthens PPD’s full range of drug development services in the country and positions it to capitalize on the tremendous growth of the outsourcing market in Asia Pacific.
buyer: PPD, Inc.
PPD is a leading global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. PPD's clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. "
target: Excel PharmaStudies Inc.
Excel PharmaStudies, Inc. is a full-service provider of clinical research, registration, biometrics, and training and consultation services. Excel is the leading CRO in China and operates 22 offices worldwide, with more than 300 staff members.
price ($mm)
$16
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/28/2009 via PR Newswire

Alpha Analytical, will acquire Boston Analytical

synopsis: Alpha Analytical is announcing the completion of the acquisition of Boston Analytical, Inc. Established in 1987, Boston Analytical is a registered, cGMP compliant contract testing laboratory providing quality analytical and microbiological testing services to the pharmaceutical, biotech, device, cosmetic and nutritional product industries.
buyer: Alpha Analytical
Alpha Analytical, Inc. provides full-service environmental laboratory solutions for the most demanding industrial and commercial applications in the U.S. and abroad. Alpha Analytical is the largest environmental laboratory in New England and among the top 18 laboratories in the country. "
target: Boston Analytical
Boston Analytical is committed to providing quality Analytical and Microbiological testing services to pharmaceutical companies worldwide in support of their Product Development, Release and Stability Testing objectives.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/12/2009 via Company Press Release

J O Hambro Capital Management Limited, acquired Celsis International

synopsis: Chicago-based Celsis International, a leading global life sciences company, announces that it has been acquired by UK-based private equity firm J O Hambro and will de-list from the London Stock Exchange (LSE) and operate as a privately held company.
buyer: J O Hambro Capital Management Limited
J O Hambro Capital Management, the London-based boutique investment firm, offers an alternative to the large traditional fund management firms that have dominated the market for many years. "
target: Celsis International
Celsis International plc is a leading international provider of innovative life science products and laboratory services to the pharmaceutical and consumer products industries through our three divisions: Rapid Detection, Analytical Services and In Vitro Technologies.
price ($mm)[EV]
$55 [$52]*
rev ($mm)
$42
EBITDA ($mm)
$12
EV / rev
1.9x
EV / EBITDA
6.3x
closed 7/16/2009 via PR Newswire

Water Street Healthcare Partners, acquired AAIPharma Services

synopsis: Water Street Healthcare Partners, a leading private equity firm focused exclusively on the health care industry, announced that it has acquired the Pharmaceutical Development division from AAIPharma Inc.
buyer: Water Street Healthcare Partners
Water Street Healthcare Partners is a leading private equity firm focused exclusively on health care. With more than $1 billion of capital under management, Water Street is one of the most active investors in the health care industry. "
target parent: AAIPharma Inc.
target: AAIPharma Services
AAIPharma Services serves more than 300 large pharmaceutical and biotechnology companies. Its team of 450 scientists and professionals specialize in services that encompass the entire process of pharmaceutical drug development from discovery through commercialization.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/1/2009 via Reuters

INC Research, Inc., will purchase Late Stage Research Unit from MDS, Inc.

synopsis: MDS Inc has announced that it planns to narrow its contract research focus by selling its late stage operations and central laboratory divisions to Contract Research Organization INC Research, Inc.
buyer: INC Research, Inc. (SYNH:$4,730.38)
INC Research is a therapeutically focused contract research organization with an unrivaled reputation for conducting Phase I- Phase IV clinical development programs of the highest integrity. "
seller: MDS, Inc. (MDZ:$231.00)
MDS Inc. is a global life sciences company that provides market-leading products and services that are used by its customers for the development of drugs, and the diagnosis and treatment of disease. The Company has more than 5,000 employees in 29 countries and net revenues of more than US$1.2 bil.
price ($mm)
$45
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/17/2009 via PR Newswire

Pierrel SpA, purchased US Operations from Encorium Group Inc.

synopsis: Encorium Group, Inc., a full service multinational clinical research organization, announced that is has completed the previously announced sale of the Company's U.S. business to Pierrel Research USA, Inc., a wholly-owned subsidiary of Pierrel SpA, an international contract research organization listed on Milano's Stock Exchange.
buyer: Pierrel SpA (PIELF:$0.00)
Pierrel S.p.A. is a pharmaceutical company specializing in contract research, development and the manufacture of medicines. The Pierrel Group boasts over 50 years of experience in the pharmaceutical sector, and is one of the main Italian manufacturers of local anaesthetics for dental use. "
seller: Encorium Group Inc.
Encorium is a full-service Contract Research Organization providing comprehensive solutions for pharmaceutical, biotechnology, and medical device companies. At Encorium we recognize the challenges that often arise during drug development.
price ($mm)[EV]
$0.08 [$2.58]
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/17/2009 via PR Newswire

ChemRar High-Tech Center, acquired Prudentas, LLC

synopsis: ChemDiv, a global chemistry-driven contract research organization, announced that its ChemRar High Tech Center has acquired Prudentas LLC, one of the leading CRO companies conducting high quality Phase I - Phase IV studies in Eastern Europe.
buyer parent: ChemDiv, Inc.
buyer: ChemRar High-Tech Center
The ChemRar High-Tech Center is a unique pharma and biotechnology complex founded by innovative life science organizations in Russia. ChemRar's component companies are engaged in discovering, developing and commercializing novel drugs for partners in Russia and worldwide. "
target: Prudentas, LLC
Prudentas is a Russian Clinical Contract Research Organization founded by and consisting of highly qualified clinical research professionals with extensive experience of working previously together as a team.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/17/2009 via PR Newswire

Chiltern International Inc., acquired Vigiun

synopsis: Chiltern International Limited, a global Clinical Research Organization (CRO) providing clinical development and staffing services in Europe, the Americas and India, announced the acquisition of Vigiun, a full service Clinical Research Organization located in Sao Paulo, Brazil.
buyer: Chiltern International Inc.
Chiltern is a global CRO with experience running and staffing international Phase I to Phase IV clinical trials. Chiltern’s services include: Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. "
target: Vigiun
Vigiun is a full service clinical research organization located in Sao Paulo, Brazil.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 4/8/2009 via PR Newswire

Next Fuel, Inc., will acquire Clinical Trials of the Americas, Inc.

synopsis: Clinical Trials of America Inc. announced that it has entered into a binding letter of intent to sell shares equal to approximately 75% of its issued and outstanding shares to Next Fuel Inc., a developer of a proprietary "On Demand" Hydrogen Generation System.
buyer: Next Fuel, Inc.
Next Fuel Inc. is a developer of a proprietary "On Demand" Hydrogen Generation System that is used as fuel for Fuel Cells which produce electricity. "
target: Clinical Trials of the Americas, Inc.
Clinical Trials of the Americas, Inc. provides clinical trial investigator services in dedicated sites throughout the Americas. Initially, we intend to introduce our services in Central America.
price ($mm)
$0.29*
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Artemis Health


read more

Artemis Health

Clearview Logix, LLC

HCMS Group LLC

PlanIT, Incorporated

Tango Health

Health E(fx)

Acclaris, Inc

PayFlex Systems USA, Inc.

BenSoft Incorporated

Tesser Health

BasicSafe

Uprise Employee Assitance

read more

Artemis Health

read more

Artemis Health

read more

Healthcare Project Management

Cogenics

Prevalere Life Sciences, Inc.

Invicro, LLC

Aptuit, Inc.

PAREXEL International Corporation

ImageIQ

inVentiv Health, Inc.

Quintiles Transnational Corp.

Bio-Quant, Inc.

BioDuro, LLC

Excel PharmaStudies Inc.

Boston Analytical

Celsis International

AAIPharma Services

MDS, Inc.

Encorium Group Inc.

Prudentas, LLC

Vigiun

Clinical Trials of the Americas, Inc.

Geography
Matching Companies
Ticker: JASDAQ:3910
 
 
 
 
 
 
 
 
MKSystem
MKSystem
MKSystem Corporation provides cloud services in Japan. It offers system development and ASP services for social insurance labor consultant offices and corporations, labor insurance administration associations, SR Labor and management centers, and general corporate human resources.
year
2016
rev ($mm)
$10.19
EBITDA ($mm)
$3.62
EBIT ($mm)
$3.17
Net Income ($mm)
$2.07
Employees
44
  • drill down
  • watch
Ticker: BME:ATRY
 
 
 
 
 
 
 
 
Atrys Health, S.A.
Atrys Health, S.A.
Atrys Health is a biomedical company in Spain dedicated to providing diagnostic services and excellent medical treatments. Their aim is to facilitate patients with individualized therapy, as well as to develop new therapeutic modalities and diagnostic tools.
year
2018
rev ($mm)
$10.43
EBITDA ($mm)
$1.46
EBIT ($mm)
$0.94
Net Income ($mm)
$0.01
Employees
99
  • drill down
  • watch
Ticker: LH
 
 
 
 
 
 
 
 
LabCorp
LabCorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialty testing laboratories. LabCorp processes tests on approximately 470,000 specimens each day, applying advances in medicine and science to laboratory testing.
year
2021
rev ($mm)
$16,388.10
EBITDA ($mm)
$4,886.00
EBIT ($mm)
$4,358.30
Net Income ($mm)
$2,878.70
Employees
68780
  • drill down
  • watch
Ticker: ENXTPA:ERF
 
 
 
 
 
 
 
 
Eurofins Group
Eurofins Group
Based in Luxembourg, Eurofins is a leading international group of laboratories providing a unique range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments.
year
2019
rev ($mm)
$5,244.00
EBITDA ($mm)
$922.65
EBIT ($mm)
$524.54
Net Income ($mm)
$224.34
Employees
47427
  • drill down
  • watch
Ticker: CRL
 
 
 
 
 
 
 
 
Charles River Laboratories International Inc.
Charles River Laboratories International Inc.
Charles River has been helping our global partners accelerate drug discovery and development by providing them with tailored research models and preclinical, clinical, support services.
year
2009
rev ($mm)
$1,202.55
EBITDA ($mm)
$282.48
EBIT ($mm)
$188.93
Net Income ($mm)
$114.44
Employees
8000
  • drill down
  • watch
Ticker: SYNH
 
 
 
 
 
 
 
 
INC Research, Inc.
INC Research, Inc.
INC Research is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries.
year
2021
rev ($mm)
$4,730.38
EBITDA ($mm)
$633.74
EBIT ($mm)
$407.86
Net Income ($mm)
$235.93
Employees
24310
  • drill down
  • watch
Ticker: ICLR
 
 
 
 
 
 
 
 
ICON Plc
ICON Plc
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development.
year
2015
rev ($mm)
$1,541.91
EBITDA ($mm)
$289.74
EBIT ($mm)
$234.82
Net Income ($mm)
$192.14
Employees
11200
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
CMIC Co., Ltd.
CMIC is a leading full-service CRO in Japan offering a wide range of services in clinical trials in Asia to both multi-national and Japanese pharma companies.
year
2019
rev ($mm)
$664.65
EBITDA ($mm)
$76.21
EBIT ($mm)
$43.15
Net Income ($mm)
$23.12
Employees
4962
  • drill down
  • watch
Ticker: NEO
 
 
 
 
 
 
 
 
NeoGenomics Laboratories
NeoGenomics Laboratories
NeoGenomics is a leading cancer diagnostic reference laboratory. NeoGenomics offers testing services for oncologists, pathologists, and pharmaceutical centers. Their areas of expertise include cancer cytogenetics, hematologic and solid tumor FISH testing, molecular oncology tests, and more.
year
2020
rev ($mm)
$444.45
EBITDA ($mm)
$23.80
EBIT ($mm)
($11.92)
Net Income ($mm)
$4.17
Employees
1700
  • drill down
  • watch
Ticker: NVTA
 
 
 
 
 
 
 
 
InVitae
Invitae, a genetic information company, is aggregating the worlds genetic tests into a single service with better quality, faster turnaround time and lower price than most single-gene tests today.
year
2021
rev ($mm)
$389.09
EBITDA ($mm)
($510.26)
EBIT ($mm)
($570.07)
Net Income ($mm)
Employees
2600
  • drill down
  • watch
Ticker: PIELF
 
 
 
 
 
 
 
 
Pierrel SpA
Pierrel SpA
Pierrel S.p.A. is a pharmaceutical company specializing in contract research, development and the manufacture of medicines. The Pierrel Group boasts over 50 years of experience in the pharmaceutical sector, and is one of the main Italian manufacturers of local anaesthetics for dental use.
year
2008
rev ($mm)
$64.38
EBITDA ($mm)
($4.23)
EBIT ($mm)
($8.92)
Net Income ($mm)
Employees
504
  • drill down
  • watch
Ticker: ENCO
 
 
 
 
 
 
 
 
Encorium Group Inc.
Encorium is a full-service Contract Research Organization providing comprehensive solutions for pharmaceutical, biotechnology, and medical device companies. At Encorium we recognize the challenges that often arise during drug development.
year
2008
rev ($mm)
$35.91
EBITDA ($mm)
($5.19)
EBIT ($mm)
($6.89)
Net Income ($mm)
Employees
226
  • drill down
  • watch
Ticker: BSEM
 
 
 
 
 
 
 
 
BioStem Technologies, Inc.
BioStem Technologies, Inc.
BioStem Technologies, Inc. is engaged in the advancement of regenerative medicine and antiaging strategies throughout the United States, Europe and Mexico. Their goal is to deliver the highest standard wellness and stem cell products that are backed by science.
year
2015
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: KRBP
 
 
 
 
 
 
 
 
Kiromic
Kiromic
Kiromic is an immuno-oncology, target discovery and gene editing company. Kiromic is developing safe tumor-specific cancer engineered immunotherapies to face and defeat multiple cancer types. The company is focused on extending the benefits of immunotherapy by leveraging their DIAMOND AI platform.
year
2021
rev ($mm)
EBITDA ($mm)
($21.04)
EBIT ($mm)
($21.30)
Net Income ($mm)
Employees
19
  • drill down
  • watch
Ticker: CNC
 
 
 
 
 
 
 
 
Centene Corporation
Centene Corporation
Centene Corporation is a leading multi-national healthcare enterprise that is committed to helping people live healthier lives. Centene Corporation provides affordable and high-quality healthcare services to members in all 50 states and around the world.
year
2020
rev ($mm)
$95,748.00
EBITDA ($mm)
$5,331.00
EBIT ($mm)
$4,247.00
Net Income ($mm)
$2,029.00
Employees
56600
  • drill down
  • watch
Ticker: MD
 
 
 
 
 
 
 
 
MEDNAX, Inc.
MEDNAX, Inc.
MEDNAX, Inc. is a national medical group that comprises the nation's leading providers of neonatal, anesthesia, maternal-fetal and pediatric medical and surgical subspecialty services. The company enhances patient outcomes and provide high-quality, cost-effective care.
year
2021
rev ($mm)
$1,796.98
EBITDA ($mm)
$214.68
EBIT ($mm)
$183.66
Net Income ($mm)
Employees
5600
  • drill down
  • watch